Progression of cutaneous melanoma: implications for treatment
- 15 August 2012
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 29 (7) , 775-796
Abstract
The survival rates of melanoma, like any type of cancer, become worse with advancing stage. Spectrum theory is most consistent with the progression of melanoma from the primary site to the in-transit locations, regional or sentinel lymph nodes and beyond to the distant sites. Therefore, early diagnosis and surgical treatment before its spread is the most effective treatment. Recently, new approaches have revolutionized the diagnosis and treatment of melanoma. Genomic profiling and sequencing will form the basis for molecular taxonomy for more accurate subgrouping of melanoma patients in the future. New insights of molecular mechanisms of metastasis are summarized in this review article. Sentinel lymph node biopsy has become a standard of care for staging primary melanoma without the need for a more morbid complete regional lymph node dissection. With recent developments in molecular biology and genomics, novel molecular targeted therapy is being developed through clinical trials.Keywords
This publication has 156 references indexed in Scilit:
- AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease OutcomeJournal of Investigative Dermatology, 2012
- β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient MelanomasCancer Cell, 2011
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?International Journal of Cancer, 2011
- Isolation of tumorigenic circulating melanoma cellsBiochemical and Biophysical Research Communications, 2010
- Correlation of molecular human leukocyte antigen typing and outcome in high‐risk melanoma patients receiving adjuvant interferonCancer, 2010
- A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the USJournal of the American College of Surgeons, 2009
- The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma – a retrospective analysis of 392 casesBritish Journal of Cancer, 2008
- Sentinel lymph node micrometastasis may predict non‐sentinel involvement in cutaneous melanoma patientsJournal of Surgical Oncology, 2008
- Beyond tumorigenesis: cancer stem cells in metastasisCell Research, 2006